Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-06-18

Clinical Trial Update: A Phase III Clinical Trial to Evaluate the Efficacy and Safety of the Live Attenuated Varicella Vaccine [Phase 3]

View source ↗

Summary

A Phase III clinical trial evaluating the efficacy and safety of a live attenuated varicella vaccine for varicella, currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Live Attenuated Varicella Vaccine (varicella vaccine, live attenuated)

Snippet

Sponsor: China National Biotec Group Company Limited | Conditions: Varicella | Phase 3 | Status: ACTIVE_NOT_RECRUITING